All News

Found 9,709 articles

• Eli Lilly and Company Announces Dividend Increase

  12/19/2005

• Saegis Pharmaceuticals, Inc. Completes Phase IIa Clinical Study Of SGS518

  12/15/2005

• Eli Lilly and Company Release: New Study Suggests Cymbalta(R) Reduced Depression Symptoms At Least As Fast As A Leading Competitor

  12/13/2005

• CeNeRx BioPharma, Inc. Appoints Chief Medical Officer

  12/13/2005

• Burrill & Company Release: Bio-Partnering Opportunities In China

  12/13/2005

• Eli Lilly and Company Release: Investigational Targeted Therapy May Offer Progress For Non-Hodgkin's Lymphoma Patients

  12/12/2005

• Eli Lilly and Company Plans To Submit Cymbalta(R) (duloxetine hydrochloride) New Drug Application For Generalized Anxiety Disorder

  12/9/2005

• Eli Lilly and Company Tells Wall Street It's Uniquely Positioned To Deliver Sustained Growth

  12/9/2005

• Michael Hanson Joins ActivBiotics Board

  12/6/2005

• InterMune, Inc. Elects David S. Kabakoff, Ph.D. To Board Of Directors

  12/2/2005

• Dr. Alpheus Bingham, InnoCentive, Inc.'s President And CEO, Receives 'Business Processes Award' At The Economist's Fourth Annual Innovation Summit

  12/1/2005

• Clarient, Inc. Enters Agreement With Eli Lilly and Company

  11/22/2005

• CalbaTech, Inc.'s Subsidiary, LifeStem Inc., Selects Leading Physician As Chief Medical Officer

  11/22/2005

• Eli Lilly and Company Announces Chemogenomics Technology Alliance And Research Collaboration Agreement With Iconix Pharmaceuticals, Inc.

  11/17/2005

• Anthera Pharmaceuticals, Inc. Appoints David E. Thompson To Board Of Directors

  11/17/2005

• Baxter International, Inc. Names Cheryl White V.P. Quality

  11/17/2005

• New Data Shows Eli Lilly and Company's ACTOS(R) (pioglitazone HCl) Reduced Heart Attacks By 28 Percent In People With Type 2 Diabetes

  11/16/2005

• Amylin Pharmaceuticals, Inc. Release: BYETTA Shown To Reduce Blood Sugar Levels When Added To Patients Treated With TZDs

  11/16/2005

• Quintiles Transnational Corp. Reports 3rd Quarter Net Revenue Of $470.3 Million, Up 19%

  11/15/2005

• AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. Announce Addition Of Ninth Board Member To Proposed Board Of Directors For Combined Company

  11/15/2005